Related Experiment Video
Updated: Aug 26, 2025

04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.8K
Enterotypes in asthenospermia patients with obesity
Jiao Jiao1,2, Peng Xu3,4, Xiaobin Wang1,2
1Center of Reproductive Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
Scientific Reports
|October 10, 2022
Summary
Gut microbiome enterotypes influence sperm quality. Obesity is linked to poorer sperm motility in men with Prevotella-dominant (P) enterotypes, but not Bacteroides-dominant (B) enterotypes.
Area of Science:
- Human Gut Microbiome Research
- Reproductive Medicine
- Nutritional Science
Background:
- Enterotypes, classifications of the gut microbiome, may influence health outcomes, including reproductive health.
- The gut microbiome composition, characterized by Prevotella and Bacteroides abundance, can be stratified into distinct enterotypes.
- Previous research suggests a link between diet, the gut microbiome, and disease risk, but the specific impact on male fertility requires further investigation.
Purpose of the Study:
- To investigate the correlation between body mass index (BMI) and asthenospermia (reduced sperm quality) within different gut microbiome enterotypes.
- To determine if enterotype classification can serve as an individualized index for assessing the risk of asthenospermia associated with obesity.
- To analyze the differential impact of obesity on sperm quality parameters in men with Prevotella-dominant (P) versus Bacteroides-dominant (B) enterotypes.
Main Methods:
- Analysis of 407 stool samples to determine gut microbiome enterotypes (P/B ratio) in men.
- Stratification of participants into enterotype P (P/B ≥ 0.01) and enterotype B (P < 0.01) groups, further categorized by normal weight and overweight/obese status.
- Statistical analysis, including odds ratios (OR) and confidence intervals (CI), to assess the association between obesity, BMI, and sperm quality parameters (forward progressive motility, total motility).
Main Results:
- In the enterotype P group, obesity was a significant risk factor for reduced forward progressive sperm motility (OR 3.350) and total sperm motility (OR 4.298).
- Obesity remained an independent risk factor for asthenospermia in enterotype P even after adjusting for follicle-stimulating hormone.
- In contrast, no significant association between obesity and impaired sperm quality parameters was observed in the enterotype B group.
Conclusions:
- Gut microbiome enterotype P is associated with increased risk of asthenospermia in overweight/obese men.
- BMI serves as a significant risk factor for asthenospermia specifically in men with enterotype P, but not in enterotype B.
- Enterotype classification offers a potential individualized approach to understanding the relationship between obesity and male fertility.
Related Concept Videos
Oogenesis
64.0K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
64.0K
Obesity
585
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
585
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
397
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
397

